Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients.

Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients. Expert Rev Anticancer Ther. 2007 May; 7(5):675-87.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.